cema-cel
Allogene Halts Leukemia CAR-T Trial Enrollment Due to Breyanzi Competition
Allogene, CAR-T therapy, leukemia, Breyanzi, Bristol Myers Squibb, cema-cel, clinical trials
Actionable Insights Powered by AI
Allogene, CAR-T therapy, leukemia, Breyanzi, Bristol Myers Squibb, cema-cel, clinical trials